150 related articles for article (PubMed ID: 24811907)
1. New preclinical porcine model of femoral head osteonecrosis to test mesenchymal stromal cell efficiency in regenerative medicine.
Poignard A; Lebouvier A; Cavet M; Rahmouni A; Flouzat Lachaniette CH; Bierling P; Rouard H; Hernigou P; Chevallier N
Int Orthop; 2014 Sep; 38(9):1837-44. PubMed ID: 24811907
[TBL] [Abstract][Full Text] [Related]
2. Development of a simple procedure for the treatment of femoral head osteonecrosis with intra-osseous injection of bone marrow mesenchymal stromal cells: study of their biodistribution in the early time points after injection.
Lebouvier A; Poignard A; Cavet M; Amiaud J; Leotot J; Hernigou P; Rahmouni A; Bierling P; Layrolle P; Rouard H; Chevallier N
Stem Cell Res Ther; 2015 Apr; 6(1):68. PubMed ID: 25889681
[TBL] [Abstract][Full Text] [Related]
3. Autologous adipose tissue-derived stem cells induce persistent bone-like tissue in osteonecrotic femoral heads.
Pak J
Pain Physician; 2012; 15(1):75-85. PubMed ID: 22270740
[TBL] [Abstract][Full Text] [Related]
4. A Mini Review: Stem Cell Therapy for Osteonecrosis of the Femoral Head and Pharmacological Aspects.
Zhao D; Liu Y; Ma C; Gu G; Han DF
Curr Pharm Des; 2019; 25(10):1099-1104. PubMed ID: 31131747
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of targeted intraarterial delivery of concentrated autologous bone marrow containing mononuclear cells in the treatment of osteonecrosis of the femoral head: a five year follow-up study.
Mao Q; Jin H; Liao F; Xiao L; Chen D; Tong P
Bone; 2013 Dec; 57(2):509-16. PubMed ID: 23994171
[TBL] [Abstract][Full Text] [Related]
6. Reprogrammed mesenchymal stem cells derived from iPSCs promote bone repair in steroid-associated osteonecrosis of the femoral head.
Zhou M; Xi J; Cheng Y; Sun D; Shu P; Chi S; Tian S; Ye S
Stem Cell Res Ther; 2021 Mar; 12(1):175. PubMed ID: 33712030
[TBL] [Abstract][Full Text] [Related]
7. Hip preserving surgery with concentrated autologous bone marrow aspirate transplantation for the treatment of asymptomatic osteonecrosis of the femoral head: retrospective review of clinical and radiological outcomes at 6 years postoperatively.
Tomaru Y; Yoshioka T; Sugaya H; Aoto K; Wada H; Akaogi H; Yamazaki M; Mishima H
BMC Musculoskelet Disord; 2017 Jul; 18(1):292. PubMed ID: 28683795
[TBL] [Abstract][Full Text] [Related]
8. Preclinical Study of Cell Therapy for Osteonecrosis of the Femoral Head with Allogenic Peripheral Blood-Derived Mesenchymal Stem Cells.
Fu Q; Tang NN; Zhang Q; Liu Y; Peng JC; Fang N; Yu LM; Liu JW; Zhang T
Yonsei Med J; 2016 Jul; 57(4):1006-15. PubMed ID: 27189298
[TBL] [Abstract][Full Text] [Related]
9. BMSC affinity peptide-functionalized β-tricalcium phosphate scaffolds promoting repair of osteonecrosis of the femoral head.
Wang G; Li Y; Sun T; Wang C; Qiao L; Wang Y; Dong K; Yuan T; Chen J; Chen G; Sun S
J Orthop Surg Res; 2019 Jul; 14(1):204. PubMed ID: 31272458
[TBL] [Abstract][Full Text] [Related]
10. HGF-transgenic MSCs can improve the effects of tissue self-repair in a rabbit model of traumatic osteonecrosis of the femoral head.
Wen Q; Jin D; Zhou CY; Zhou MQ; Luo W; Ma L
PLoS One; 2012; 7(5):e37503. PubMed ID: 22629409
[TBL] [Abstract][Full Text] [Related]
11. Treatment of osteonecrosis of the femoral head with VEGF165 transgenic bone marrow mesenchymal stem cells in mongrel dogs.
Hang D; Wang Q; Guo C; Chen Z; Yan Z
Cells Tissues Organs; 2012; 195(6):495-506. PubMed ID: 22056983
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of autologous stem cell-based therapy for osteonecrosis of the femoral head in sickle cell disease: a five-year follow-up study.
Daltro GC; Fortuna V; de Souza ES; Salles MM; Carreira AC; Meyer R; Freire SM; Borojevic R
Stem Cell Res Ther; 2015 May; 6(1):110. PubMed ID: 26021713
[TBL] [Abstract][Full Text] [Related]
13. Stem Cell Therapy for Osteonecrosis of the Femoral Head: Current Trends and Comprehensive Review.
Zhao L; Kaye AD; Kaye AJ; Abd-Elsayed A
Curr Pain Headache Rep; 2018 May; 22(6):41. PubMed ID: 29725783
[TBL] [Abstract][Full Text] [Related]
14. Effects of sclerotic changes on stress concentration in early-stage osteonecrosis: A patient-specific, 3D finite element analysis.
Utsunomiya T; Motomura G; Ikemura S; Kubo Y; Sonoda K; Hatanaka H; Baba S; Kawano K; Yamamoto T; Nakashima Y
J Orthop Res; 2018 Dec; 36(12):3169-3177. PubMed ID: 30098226
[TBL] [Abstract][Full Text] [Related]
15. Stromal-Cell-Derived Factor (SDF) 1-Alpha Overexpression Promotes Bone Regeneration by Osteogenesis and Angiogenesis in Osteonecrosis of the Femoral Head.
Yang F; Xue F; Guan J; Zhang Z; Yin J; Kang Q
Cell Physiol Biochem; 2018; 46(6):2561-2575. PubMed ID: 29758548
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers of bone healing induced by a regenerative approach based on expanded bone marrow-derived mesenchymal stromal cells.
Granchi D; Ciapetti G; Gómez-Barrena E; Rojewski M; Rosset P; Layrolle P; Spazzoli B; Donati DM; Baldini N
Cytotherapy; 2019 Aug; 21(8):870-885. PubMed ID: 31272868
[TBL] [Abstract][Full Text] [Related]
17. An exploratory study of articular cartilage and subchondral bone reconstruction with bone marrow mesenchymal stem cells combined with porous tantalum/Bio-Gide collagen membrane in osteonecrosis of the femoral head.
Liu B; Yang F; Wei X; Zhang X; Zhang Y; Wang B; Liu G; Xie H; Yang J; Wang W; Qin K; Zhao D
Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():1123-1132. PubMed ID: 30889646
[TBL] [Abstract][Full Text] [Related]
18. Effect of Allogeneic Cell-Based Tissue-Engineered Treatments in a Sheep Osteonecrosis Model.
López-Fernández A; Barro V; Ortiz-Hernández M; Manzanares MC; Vivas D; Vives J; Vélez R; Ginebra MP; Aguirre M
Tissue Eng Part A; 2020 Sep; 26(17-18):993-1004. PubMed ID: 32122263
[TBL] [Abstract][Full Text] [Related]
19. Investigational regenerative medicine for non-traumatic osteonecrosis of the femoral head: a survey of registered clinical trials.
Kuroda Y; Kawai T; Okuzu Y; Morita Y; Matsuda S
Expert Opin Investig Drugs; 2024 Apr; 33(4):405-414. PubMed ID: 38431280
[TBL] [Abstract][Full Text] [Related]
20. Stem Cells Combined With Platelet-rich Plasma Effectively Treat Corticosteroid-induced Osteonecrosis of the Hip: A Prospective Study.
Houdek MT; Wyles CC; Collins MS; Howe BM; Terzic A; Behfar A; Sierra RJ
Clin Orthop Relat Res; 2018 Feb; 476(2):388-397. PubMed ID: 29529674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
